CN101293028B - Medicament for treating hepatitis B - Google Patents
Medicament for treating hepatitis B Download PDFInfo
- Publication number
- CN101293028B CN101293028B CN2008101237470A CN200810123747A CN101293028B CN 101293028 B CN101293028 B CN 101293028B CN 2008101237470 A CN2008101237470 A CN 2008101237470A CN 200810123747 A CN200810123747 A CN 200810123747A CN 101293028 B CN101293028 B CN 101293028B
- Authority
- CN
- China
- Prior art keywords
- gram
- drug
- herb
- herba
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a drug for treating hepatitis B, which is prepared by Chinese herbal medicines. The drug is characterized in that the drug comprises the main drugs with the following weights: 80 to 160g of Mongolian dandelion herb, 100 to 200g of humifuse euphorbia herb, 80 to 160g of cudrania cochinchinensis, 80 to 160g of sun euphorbia herb, 90 to 180g of common knotgrass herb and 130 to 240g of root of hedge glorybind; and the adjuvant with the following weight: 90 to 170g of white mulberry root-bark. The whole formula has perfect compatibility, powerful drug efficacy and orderly sequence, which can hit the disease mechanism and fully reflect the treatment principles of clearing heat, removing toxin, activating blood circulation, dredging channels, promoting diuresis, removingedema, resolving phlegm, abating jaundice and invigorating essential qi.
Description
Technical field
The B-mode dried scorching medicine of the present invention and a kind of treatment, the medicine that particularly utilizes Chinese herbal medicine to make.
Background technology
Hepatitis B is the common frequently-occurring diseases of people, shows that according to health bureau's door investigation the hepatitis B virus infection person whole nation surpasses 100,000,000, and along with the population mobility strengthens, various infection chances are also increasing, and hepatitis B is a kind of pertinacious disease.In case morbidity is difficult to cure, because hepatitis B can not get timely and effective treatment, patient's dysfunction of the liver and gallbladder in governing normal flow of QI, the transporting and transforming function of the spleen and stomach conduction is unable, and diet is precise and tiny must not normally fail cloth, so decline healthy energy day.Even develop into liver cirrhosis or hepatocarcinoma.State of an illness tinge is rung work, learns, is chosen spouse, social activity, and what the state of an illness was heavy loses one's life, and brings heavy burden for social family.Western medical treatment hepatitis B, the main use are given birth to the kobold sheet that goes out at present, and liver must wait medicine can only control for the moment again, and also has side effect.It is little that Chinese medicine and Western medicine are compared apparent side effect, curative effect is lasting, therapeutic effect is good, as ganlu xiaodu micropills is exactly a kind of fine medicine, its Main Ingredients and Appearance is Talcum, Radix Scutellariae, Herba Artemisiae Scopariae, Rhizoma Acori Graminei, Herba Pogostemonis, Rhizoma Belamcandae, Fructus Forsythiae, Fructus Amomi Rotundus, Herba Menthae, Caulis Akebiae, Bulbus Fritillariae Cirrhosae, exist easy recurrence in actual the use, the shortcoming that the course of treatment is long.
Summary of the invention
Purpose of the present invention is exactly that prior art exists shortcoming and a kind of medicine with treatment hepatitis B that compatibility of drugs is perfect, side effect is little, cure rate is high is provided.
To achieve these goals, the present invention adopts following technical scheme:
A kind of medicine for the treatment of hepatitis B, it is characterized in that it is made up of the raw medicinal material of following weight: Herba Taraxaci 80-160 gram, Herba Euphorbiae Humifusae 100-200 gram, Radix Cudraniae 80-160 gram, Herba Euphorbiae Helioscopiae 80-160 Ke, Herba Polygoni Avicularis 90-180 gram, Radix Calystegiae sepii 130-240 gram, Cortex Mori 90-170 gram.
Realize preferred plan of the present invention by component weight:
Herba Taraxaci 120 grams, Herba Euphorbiae Humifusae 150 grams, Radix Cudraniae 120 grams, Herba Euphorbiae Helioscopiae 120 Ke, Herba Polygoni Avicularis 140 grams, Radix Calystegiae sepii 180 grams, Cortex Mori 120 grams.
The preparation scheme of medicine of the present invention is:
With Herba Taraxaci, Herba Euphorbiae Humifusae, Radix Cudraniae, Herba Euphorbiae Helioscopiae, Herba Polygoni Avicularis, Radix Calystegiae sepii, Cortex Mori is dried respectively, is pulverized, and crosses 100 mesh sieves, and the mixing sterilization incapsulates, and each capsule is finished product by 0.35 gram dress.
Profitable fruit:
The present invention treats the Chinese medicine of hepatitis B, each Chinese medicine component: Herba Taraxaci, Herba Euphorbiae Humifusae two medicines are combined with the effect of heat-clearing and toxic substances removing.Radix Cudraniae has promoting blood circulation to remove obstruction in the collateral, the effect of jaundice eliminating subcutaneous ulcer.That Herba Euphorbiae Helioscopiae, Herba Polygoni Avicularis, Cortex Mori have is inducing diuresis and reducing edema, the effect of expectorant, jaundice eliminating subcutaneous ulcer.The useful vital essence of Radix Calystegiae sepii is controlled the effect of erysipelas.Therefore, the function of heat-clearing and toxic substances removing of the present invention, promoting blood circulation to remove obstruction in the collateral, inducing diuresis and reducing edema, expectorant jaundice eliminating subcutaneous ulcer, nourishing the essence and strengthening QI.
The present invention compares with the traditional treatment hepatitis B and has following characteristics:
Pharmaceutical purity Chinese medicine preparation of the present invention, side effect is little, has solved traditional side's medicine being attacked by dampness, heat, poison, the not beneficial tonification problem of harmony resistance, stable curative effect, medical expense is low.
Chinese medicine indication of the present invention: hepatitis B.
Instructions of taking: oral, every day three times, warm water delivery service, the age, critical illness cut down according to the circumstance more than 70 years old below 14 years old.
For showing that Chinese medicine of the present invention is to the treating hepatitis B effect.Through 2 routine clinical treatment observations: male's 1 example, women's 1 example, the age was respectively 31 years old, 55 years old.
One, diagnostic criteria: 2 examples are all made a definite diagnosis through regular hospital.
Two, observational technique: observe the clinical symptoms performance of treatment front and back.
Three, medication: increase gradually from every day three times at every turn, promptly stop to increase if any xerostomia, polyuria phenomenon.Add at most till 10.One month is a course of treatment, finishes check the course of treatment, the method for own control before and after adopting, the other medicines of stopping using during the treatment.
Four, curative effect determinate standard:
1, cure: symptomatology is eliminated or is mainly demonstrate,proved shape and eliminates.Commentaries on classics peace enzyme index recovers normal and big and small three Yang is turned out cloudy, and does not recur in 1 year.
2, effective: as to demonstrate,prove mainly that shape takes a turn for the better or have made marked progress.
3, invalid: as all not have progress with the preceding relatively each side of treatment
Five, observe conclusion: 2 examples are all cured.
Herba Taraxaci 120 grams, Herba Euphorbiae Humifusae 150 grams, Radix Cudraniae 120 grams, Herba Euphorbiae Helioscopiae 120 Ke, Herba Polygoni Avicularis 140 grams, Radix Calystegiae sepii 180 grams, Cortex Mori 120 grams are dried respectively, are pulverized, cross 100 mesh sieves, sterilization incapsulates (each capsule is by 0.35 gram dress), eliminating cold for resuscitation water send down, and obeying a beginning for the first time increases gradually.See xerostomia is arranged, polyuria just stops to increase, and adds to 10 as nothing, days three times, one month is a course of treatment, the age is below 14 years old, more than 70 years old or body constitution cut down according to the circumstance a little less than.
The specific embodiment
Chen Suhua, the woman, nineteen fifty-three gives birth to, and in April, 2006 occurs poor appetite, and symptom such as feel sick, anorexia is greasy is confirmed as hepatitis B to this county's county hospital inspection, cures four courses of treatment with medicine of the present invention, and it is normal substantially to arrive the every index of examination in hospital, does not see recurrence so far
Wang Yingxin, the man, life in 1978,2004 tested find great three positive after, successively in Shanghai, ground hospitalizes such as Chongqing, Beijing, send out repeatedly and do, in January, 2006, patient mother-in-law looked for me to treat, through 5 the medication treatments course of treatment, obtain clinical cure, do not see recurrence so far.
Claims (1)
1. medicine for the treatment of hepatitis B, it is characterized in that it is made up of the raw medicinal material of following weight, Herba Taraxaci 80-160 gram, Herba Euphorbiae Humifusae 100-200 gram, Radix Cudraniae 80-160 gram, Herba Euphorbiae Helioscopiae 80-160 gram, Herba Polygoni Avicularis 90-180 gram, Radix Calystegiae sepii 130-240 gram, Cortex Mori 90-170 gram.Above medical material drying is pulverized the capsule of making.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101237470A CN101293028B (en) | 2008-06-02 | 2008-06-02 | Medicament for treating hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101237470A CN101293028B (en) | 2008-06-02 | 2008-06-02 | Medicament for treating hepatitis B |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101293028A CN101293028A (en) | 2008-10-29 |
| CN101293028B true CN101293028B (en) | 2010-12-08 |
Family
ID=40063736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101237470A Expired - Fee Related CN101293028B (en) | 2008-06-02 | 2008-06-02 | Medicament for treating hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101293028B (en) |
-
2008
- 2008-06-02 CN CN2008101237470A patent/CN101293028B/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 姜宜孙.清肝解毒法为主治疗化学药物引起肝脏损害31例的体会.《中医杂志》.1988,(第3期),47－49. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101293028A (en) | 2008-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1342462A (en) | Composite medicine for treating rheumatoid arthritis | |
| CN101810761A (en) | Medicament for treating tuberculosis | |
| CN101129872A (en) | Powder of phellodendron amurense adlay erysipelas | |
| CN102688434B (en) | Traditional Chinese medicine (TCM) for treating diabetes | |
| CN103041241B (en) | Compound psoriasis arthropathica removal decoction | |
| CN106692909A (en) | Pyrus pyrifolia tree viscum coloratum grease with lung-clearing and phlegm-eliminating effects | |
| CN102743539B (en) | Traditional Chinese medicine for treating coronary heart disease with warming yang and promoting blood circulation effects, and preparation method for same | |
| CN102451354A (en) | Preparation method for Chinese medicine for treating acute pancreatitis | |
| CN102319376B (en) | Chinese herbal medicament for treating nephropathy | |
| CN101293028B (en) | Medicament for treating hepatitis B | |
| CN103830672A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis | |
| CN1325096C (en) | Chinese medicine formulation for treating ance disease | |
| CN102670919A (en) | Chinese medicament for treating chronic pyelonephritis | |
| CN102370853A (en) | Traditional Chinese medicine for treating chronic pyelonephritis | |
| CN102028909B (en) | Fumigant for treating parapsoriasis guttata | |
| CN104887970A (en) | Acupuncture and moxibustion physiotherapy ointment for external use | |
| CN100427132C (en) | Traditional Chinese medicine for treating rheumatism and its preparing process | |
| CN104248677A (en) | Traditional Chinese medicinal preparation for treating erythema multiforme | |
| CN102743599A (en) | Traditional Chinese medicine for treating diabetes | |
| CN102784344B (en) | Traditional Chinese medicine preparation for treating pulmonary tuberculosis | |
| CN101596255B (en) | Chinese medicament for preventing and curing leucemia | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN104800688A (en) | Traditional Chinese medicine composition for treating chronic nephritis and application | |
| CN101690771B (en) | Medicine for curing chronic enteritis | |
| CN103989885A (en) | Traditional Chinese medicine for treating chronic pelvic inflammation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101208 Termination date: 20130602 |